Industries > Pharma > Vaccine Contract Manufacturing Market Forecast 2020-2030

Back to Pharma Reports

Vaccine Contract Manufacturing Market Forecast 2020-2030

Prospects for Attenuated Vaccine, Inactivated Vaccine, Fluoroquinolones, Subunit Vaccines, Toxoid Vaccines PLUS analysis in leading companies within Vaccine Contract Manufacturing

PUBLISHED: 08 April 2020

PAGES: 290

PRODUCT CODE: PHA0735

SUBMARKET: Biotechnology Contract Services Next Generation Technologies

SKU: PHA0735 Categories: Biotechnology, Contract Services, Next Generation Technologies, Pharma Tags: PHA0519, PHA0735, PHA0736, PHA0739, PHA0808, PHA0809, PHA0926, PHA0929, PHA0941, PHA1019, PHA1024, PHA1071, PHA1078, PHA1080, PHA1123, PHA1130, PHA1137, PHA1140, PHA1149, PHA1156

The global vaccine contract manufacturing market was worth $2,241.6m in 2019 and is expected to grow at a CAGR of 9.3% from 2020-2025.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 290-page report you will receive 89 tables and 105 figures– all unavailable elsewhere.

The 290-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine market

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market by type:
• Attenuated Vaccines
• Inactivated Vaccines
• Fluoroquinolones
• Subunit Vaccines
• Toxoid Vaccines

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market by workflow:
• Downstream Processing: the revenues are further broken down into Fill & Finish Operations, Analytical & QC Studies, Packaging
• Upstream Processing: the revenues are further broken down into Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

• Revenue and growth forecasts from 2020 to 2030 for the leading regional and national markets:
• North America: the revenues are further broken down into the US and Canada
• Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
• Asia-Pacific: the revenues are further broken down into China, Japan, India and Rest of Asia-Pacific
• Latin America: the revenues are further broken down into Brazil, Mexico, and Rest of Latin America
• Middle East & Africa: the revenues are further broken into Saudi Arabia, South Africa and Rest of Middle East & Africa

The regional markets are further broken down by type and workflow.

• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• AbbVie
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• IDT Biologika
• Lonza
• Meridan Lifescience
• Pfizer
• And many more

• A SWOT analysis discussing the industry trends, strengths, weaknesses, opportunities and threats.

• Discussion on vaccine manufacturing technologies covering new substrates for vaccine production, next-generation expression systems and vectors, equipment trends, pre-filled syringes and vaccines, lyophilization and vaccine manufacturing, cell-based techniques.

• Key Questions Answered by this Report:
• How is the vaccine contract manufacturing market evolving?
• What is driving and restraining the vaccine contract manufacturing market?
• What are the market shares of the leading segments of the vaccine contract manufacturing market in 2019?
• What is the value of the leading sectors in important regions of the world?
• What will be the main driver of the overall market from 2020 to 2030?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the leading national markets change by 2030 and which country will lead the market in 2030?
• How will the industry evolve during the period between 2020 and 2030?

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Vaccine Contract Manufacturing Market Research: Prospects for Attenuated Vaccine, Inactivated Vaccine, Fluoroquinolones, Subunit Vaccines, Toxoid Vaccines. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

1. Report Overview

1.1 Global Vaccine Contract Manufacturing Market Overview

1.2 Overview of Findings

1.3 Structure of the Report

1.4 Global Vaccine Contract Manufacturing Market Segmentation

1.5 Why You Should Read This Report

1.6 How This Report Delivers

1.7 Key Questions Answered by This Analytical Report

1.8. Who is This Report For?

1.9 Methodology

1.10 Associated Visiongain Reports

1.11 About Visiongain

2. Introduction to Vaccines

2.1 The History of Vaccines

2.2 How Do Vaccines Work?

2.3 Types of Vaccine

2.3.1 Attenuated Vaccine

2.3.2 Inactivated Vaccine

2.3.2 Inactivated Vaccine

2.3.4. Subunit Vaccines

2.3.4.1. Recombinant Subunit Vaccines

2.3.4.1. Recombinant Subunit Vaccines

2.3.4.1. Recombinant Subunit Vaccines

2.3.7 Therapeutic Vaccines

2.4 The Rise of the Vaccines Market

2.5 Technological and Regulatory Improvements

2.6 Vaccine Manufacturing Technologies

2.7 New Substrates for Vaccine Production

2.7.1 Shift towards Cell-Based Manufacturing Technology

2.7.2 Benefits of Cell-Based Techniques

2.8 Drivers

2.8.1 Global increase in vaccination coverage

2.8.2 Cost and time saving benefits offered by contract services

2.9 Restraint

2.9.1 Limited outsourcing by well-established vaccine manufacturers

2.9.2. Other restrains

3. Vaccine Contract Manufacturing Market, 2020-2030

3.1 The Global Vaccine Contract Manufacturing Market: Market Overview

3.2 Outsourcing in the Pharmaceutical and Biotechnology Industry

3.3 Global Vaccine Contract Manufacturing Market: Revenue Forecast 2020-2030

3.4 Global Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

3.5 Changing Market Shares by Segment 2020-2030

3.6 Attenuated Vaccine: Revenue Forecast, 2018-2030

3.7 Inactivated Vaccine: Revenue Forecast, 2018-2030

3.8 Fluoroquinolones: Revenue Forecast 2018-2030

3.9 Subunit Vaccines: Revenue Forecast 2018-2030

3.10 Toxoid Vaccines: Revenue Forecast 2018-2030

3.11 Others: Revenue Forecast 2018-2030

4. Vaccine Contract Manufacturing Market, by Workflow, 2020-2030

4.1 The Global Vaccine Contract Manufacturing Market: Market Overview

4.2 Global Vaccine Contract Manufacturing Market, By Workflow: Revenue Forecast 2020-2030

4.3 Changing Market Shares by Segment 2020-2030

4.4 Downstream Processing

4.4.1 Fill & Finish Operations: Revenue Forecast 2018-2030

4.4.2 Analytical & QC studies: Revenue Forecast, 2018-2030

4.4.3 Packaging: Revenue Forecast 2018-2030

4.5 Upstream Processing

4.5.1 Mammalian Expression Systems: Revenue Forecast 2018-2030

4.5.2 Bacterial Expression Systems: Revenue Forecast 2018-2030

4.5.3 Yeast Expression Systems: Revenue Forecast 2018-2030

4.5.4 Baculovirus/Insect Expression Systems: Revenue Forecast, 2018-2030

4.5.6 Others: Revenue Forecast, 2018-2030

5. Vaccine Contract Manufacturing Market, By Application, 2020-2030

5.1 The Global Vaccine Contract Manufacturing Market: Market Overview

5.2 Global Vaccine Contract Manufacturing Market: Revenue Forecast 2020-2030

5.3 Changing Market Shares by Segment 2020-2030

5.4 Paediatric Vaccines: Revenue Forecast, 2018-2030

5.5 Adult Vaccines: Revenue Forecast, 2018-2030

5.6 Influenza Vaccines: Revenue Forecast, 2018-2030

5.7 Therapeutic Vaccines: Revenue Forecast, 2018-2030

6. Leading National Markets 2020-2030

6.1. Geographical Breakdown of the World Vaccine Contract Manufacturing Market

6.2 World Vaccine Contract Manufacturing Market: Regional Forecast 2020-2030

6.2.1 How Will Regional Market Shares Change to 2030?

7. North America Vaccine Contract Manufacturing Market 2020-2030

7.1. North America Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030

7.2. North America Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030

7.3. US Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

7.4. Canada Vaccine Contract Manufacturing Market: Trends and Developments

8. Europe Vaccine Contract Manufacturing Market 2020-2030

8.1. Europe Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030

8.2. Europe Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030

8.3 Europe Markets: Changing Market Shares by Country, 2020-2030

8.4. Germany Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

8.5. France Vaccine Contract Manufacturing Market: Trends and Developments

8.6. U.K. Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

8.7. Italy Vaccine Contract Manufacturing Market: Trends and Developments

8.8. Spain Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

8.9. Rest of Europe Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

9. Asia Pacific Vaccine Contract Manufacturing Market 2020-2030

9.1. Asia Pacific Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030

9.2. Asia Pacific Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030

9.3. Japan Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

9.4. China Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

9.5. India Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

9.6. Rest of Asia Pacific Vaccine Contract Manufacturing Market: Trends and Developments

10. Latin America Vaccine Contract Manufacturing Market 2020-2030

10.1. Latin America Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030

10.2. Latin America Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030

10.3. Brazil Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

10.4. Mexico Vaccine Contract Manufacturing Market: Trends and Developments

10.5. Rest of Latin America Vaccine Contract Manufacturing Market: Trends and Developments

11. Middle East & Africa Vaccine Contract Manufacturing Market 2020-2030

11.1. Middle East & Africa Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030

11.2. Middle East & Africa Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030

11.3. Saudi Arabia Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

11.4. South Africa Vaccine Contract Manufacturing Market: Trends and Developments

11.5. Rest of Middle East & Africa Vaccine Contract Manufacturing Market: Trends and Developments

12. Leading Companies in the Vaccine Contract Manufacturing Market, 2020

12.1 LONZA

12.1.1 Overview

12.1.2 Lonza: Products and Services Offered

12.1.3 Lonza: Financial Overview

12.1.4 Recent Transactions Summary

12.2 Pfizer, Inc.

12.2.1 Overview

12.2.2 Pfizer: Products and Services Offered

12.2.3 Pfizer, Inc.: Financial Overview

12.2.4 Recent Transactions Summary

12.3 Merck & Co., Inc.

12.3.1 Overview

12.3.2 Merck & Co., Inc.: Products and Services Offered

12.3.3 Merck & Co., Inc..: Financial Overview

12.3.4 Recent Transactions Summary

12.4 AbbVie

12.4.1 Overview

12.4.2 AbbVie: Vaccine Contract Manufacturing Product/Services Portfolio

12.4.3 AbbVie: Financial Overview

12.4.4 AbbVie: Recent Transactions Summary

12.5 Baxter (Baxter BioPharma Solutions)

12.5.1 Overview

12.5.2 Baxter: Vaccine Contract Manufacturing Product/Services Portfolio

12.5.3 Baxter: Financial Overview

12.5.4 Recent Transactions Summary

12.6 Catalent, Inc.

12.6.1 Overview

12.6.2 Catalent, Inc.: Vaccine Contract Manufacturing Product/Services Portfolio

12.6.3 Catalent, Inc.: Financial Overview

12.6.4 Recent Transactions Summary

12.7 PRA Health Sciences

12.7.1 Overview

12.7.2 PRA Health Sciences, Inc.: Vaccine Contract Manufacturing Product/Services Portfolio

12.7.3 PRA Health Sciences, Inc.: Financial Overview

12.7.4 Recent Transactions Summary

12.8 KBI Biopharma, Inc.

12.8.1 Overview

12.8.2 KBI Biopharma, Inc.: Vaccine Contract Manufacturing Product/Services Portfolio

12.8.3 Recent Transactions Summary

12.9 Charles River Laboratories

12.9.1 Overview

12.9.2 Charles River Laboratories: Vaccine Contract Manufacturing Product/Services Portfolio

12.9.3 Charles River Laboratories: Financial Overview

12.9.4 Recent Transactions Summary

12.10 Boehringer Ingelheim

12.10.1 Overview

12.10.2 Boehringer Ingelheim: Vaccine Contract Manufacturing Product/Services Portfolio

12.10.3 Boehringer Ingelheim: Financial Overview

12.10.4 Recent Transactions Summary

12.11 IDT Biologika GmbH

12.11.1 Overview

12.11.2 IDT Biologika GmbH: Vaccine Contract Manufacturing Product/Services Portfolio

12.11.3 Recent Transactions Summary

12.12 Meridian Life Science

12.12.1 Overview

12.12.2 Meridian Life Science: Vaccine Contract Manufacturing Product/Services Portfolio

12.12.3 Meridian Life Science: Financial Overview

12.12.4 Recent Transactions Summary

13. Qualitative Analysis of the Vaccine Contract Manufacturing Market, 2020-2030

13.1. Vaccine Contract Manufacturing Industry Trends

13.2 Strengths and Weaknesses of the Vaccine Contract Manufacturing Market, 2020

13.2.1 Strengths

13.2.1.1 Cost of in-house capabilities

13.2.1.2 Outsourcing Improves Time to Market

13.2.1.3 Manufacturers Get Access to Specialised Technologies

13.2.1.3 Manufacturers Get Access to Specialised Technologies

13.2.2 Weaknesses

13.2.2.1 Mass Vaccine Manufacturing Kept In-house

13.2.2.2. A Highly-Fragmented Vaccine Contract Manufacturing Market

13.2.3. Opportunities

13.2.3.1 Many Vaccines in the Product Pipeline

13.2.3.2 Emerging Market’s Growing Demand for Vaccines

13.2.3.3 Dynamic Change: Emerging Markets are Major Vaccine Developers

13.1.3.4. Changing World Demographics

13.2.4. Threats

13.2.4.1 Post Recession: Biotech Suffer from Severe Cuts in Capital Funding

13.2.4.2 The Public are Slow to Accept Novel Technologies

13.2.4.3 Perception of Risk by the Original Vaccine Manufacturers

13.3 Vaccine Contract Manufacturing Drivers and Restraints, 2020-2030

14. Conclusions

14.1 Overview of Current Market Conditions and Market Forecast, 2020-2030

14.2 Attenuated Vaccine Will Remain the Dominant Vaccine Type

14.3 Leading Regions in the Vaccine Contract Manufacturing Market in 2018

14.4 Trends in the Vaccine Contract Manufacturing Market

Glossary

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain report evaluation form

List of Figures

Figure 1.1 Global Vaccine Contract Manufacturing Market Segmentation Overview

Figure 3.1 Vaccine Contract Manufacturing Market: Market Share (%) by Vaccine Type, 2019

Figure 3.2 Vaccine Contract Manufacturing Market: Market Share (%) by Class, 2020

Figure 3.3 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 3.4 The Global Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2018

Figure 3.5 The Global Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2019

Figure 3.6 The Global Vaccine Contract Manufacturing Market Forecast by Vaccine Type: CAGR (%), 2020-2030

Figure 3.7 The Vaccine Contract Manufacturing Market Segments: Revenue* ($m) Forecast, 2018-2030

Figure 3.8 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2018

Figure 3.9 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2024

Figure 3.10 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2030

Figure 3.11 Global Attenuated Vaccine Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 3.12 Global Inactivated Vaccine Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030

Figure 3.13 Global Fluoroquinolones Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030

Figure 3.14 Global Subunit Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030

Figure 3.15 Global Toxoid Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030

Figure 3.16 Others Drugs Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 4.1 Vaccine Contract Manufacturing Market: Market Share (%) by Workflow, 2019

Figure 4.2 Vaccine Contract Manufacturing Market: Market Share (%) by Class, 2020

Figure 4.3 The Global Vaccine Contract Manufacturing Market Forecast by Workflow, 2019

Figure 4.4 The Global Vaccine Contract Manufacturing Market Forecast by Workflow, 2020

Figure 4.5 The Global Vaccine Contract Manufacturing Market Forecast by Workflow: CAGR (%), 2020-2030

Figure 4.6 The Vaccine Contract Manufacturing Market Segments: Revenue* ($m) Forecast, 2018-2030

Figure 4.7 Global Vaccine Contract Manufacturing Market by Workflow: Market Share (%), 2019

Figure 4.8 Global Vaccine Contract Manufacturing Market by Workflow: Market Share (%), 2024

Figure 4.9 Global Vaccine Contract Manufacturing Market by Workflow: Market Share (%), 2030

Figure 4.10 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Revenue* ($m) Forecasts by Segment,2018-2030

Figure 4.11 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Market Share (%), 2019

Figure 4.12 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Market Share (%), 2024

Figure 4.13 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Market Share (%), 2030

Figure 4.14 Global Fill & Finish Operations Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 4.15 Global Analytical & QC studies Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 4.16 Global Packaging Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 4.17 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Revenue* ($m) Forecasts by Segment,2018-2030

Figure 4.18 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Market Share (%), 2019

Figure 4.19 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Market Share (%), 2024

Figure 4.20 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Market Share (%), 2030

Figure 4.21 Global Mammalian Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 4.22 Global Bacterial Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 4.23 Global Yeast Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 4.24 Global Baculovirus/Insect Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 4.25 Global Others Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 5.1 Vaccine Contract Manufacturing Market: Market Share (%) by Application, 2019

Figure 5.2 Vaccine Contract Manufacturing Market: Market Share (%) by Class, 2020

Figure 5.3 The Global Vaccine Contract Manufacturing Market Forecast by Application, 2018

Figure 5.4 The Global Vaccine Contract Manufacturing Market Forecast by Application, 2019

Figure 5.5 The Global Vaccine Contract Manufacturing Market Forecast by Application: CAGR (%), 2020-2030

Figure 5.6 The Vaccine Contract Manufacturing Market Segments: Revenue* ($m) Forecast, 2018-2030

Figure 5.7 Global Vaccine Contract Manufacturing Market by Application: Market Share (%), 2018

Figure 5.8 Global Vaccine Contract Manufacturing Market by Application: Market Share (%), 2024

Figure 5.9 Global Vaccine Contract Manufacturing Market by Application: Market Share (%), 2030

Figure 5.10 Global Paediatric Vaccines Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 5.11 Global Adult Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030

Figure 5.12 Global Influenza Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030

Figure 5.13 Global Therapeutic Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030

Figure 6.1 World Vaccine Contract Manufacturing Market: Revenues ($ m) by Region, 2018

Figure 6.2 World Vaccine Contract Manufacturing Market: Revenues ($ m) by Region, 2019

Figure 6.3 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 6.4 World Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2019

Figure 6.5 World Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2024

Figure 6.6 World Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2030

Figure 7.1 North America Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 7.2 North America Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2019

Figure 7.3 North America Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2024

Figure 7.4 North America Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2030

Figure 7.5 U.S. Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030

Figure 7.6 Canada Vaccine Contract Manufacturing Market Forecast: Revenues($m), AGR (%), 2018-2030

Figure 8.1 Europe Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019

Figure 8.2 Europe Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 8.3 Europe Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2018

Figure 8.4 Europe Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024

Figure 8.5 Europe Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030

Figure 8.6 Germany Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030

Figure 8.7 France Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030

Figure 8.8 U.K. Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030

Figure 8.9 Italy Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030

Figure 8.10 Spain Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030

Figure 8.11 Rest of Europe Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030

Figure 9.1 Asia Pacific Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019

Figure 9.2 Asia Pacific Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 9.3 Asia Pacific Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2019

Figure 9.4 Asia Pacific Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024

Figure 9.5 Asia Pacific Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030

Figure 9.6 Japan Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030

Figure 9.7 China Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030

Figure 9.8 India Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030

Figure 9.9 Rest of Asia Pacific Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030

Figure 10.1 Latin America Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019

Figure 10.2 Latin America Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 10.3 Latin America Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2019

Figure 10.4 Latin America Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024

Figure 10.5 Latin America Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030

Figure 10.6 Brazil Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030

Figure 10.7 Mexico Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030

Figure 10.8 Rest of Latin America Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030

Figure 11.1 Middle East & Africa (MEA) Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019

Figure 11.2 Middle East & Africa Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030

Figure 11.3 Middle East & Africa Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2019

Figure 11.4 Middle East & Africa Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024

Figure 11.5 Middle East & Africa Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030

Figure 11.6 Saudi Arabia Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030

Figure 11.7 South Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030

Figure 11.8 Rest of Middle East & Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030

Figure 12.1 : Lonza Revenue ($m), AGR (%), 2015-2019

Figure 12.2 Lonza: Business Segment Revenue Share (%), 2018

Figure 12.3 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018

Figure 12.4 Pfizer, Inc.: Business Segment Revenue Share (%), 2018

Figure 12.5 Pfizer, Inc.: Region Revenue Share (%), 2018

Figure 12.6 Merck & Co, Inc.: Revenue ($m), AGR (%), 2015-2019

Figure 12.7 Merck & Co., Inc.: Business Segment Revenue Share (%), 2019

Figure 12.8 Merck & Co., Inc.: Region Revenue Share (%), 2019

Figure 12.9 AbbVie: Revenue ($m), AGR (%), 2015-2019

Figure 12.10 AbbVie: Business Segment Revenue Share (%), 2019

Figure 12.11 AbbVie: Region Revenue Share (%), 2019

Figure 12.12 Baxter: Revenue ($m), AGR (%), 2014-2018

Figure 12.13 Baxter: Business Segment Revenue Share (%), 2018

Figure 12.14 Baxter: Breakdown of Revenue (%) by Region, 2018

Figure 12.15 Catalent, Inc.: Revenue ($m), AGR (%), 2015-2019

Figure 12.16 Catalent, Inc.: Business Segment Revenue Share (%), 2019

Figure 12.17 Catalent, Inc.: Reporting Segment Revenue Share (%), 2019

Figure 12.18 Catalent, Inc.: Breakdown of Revenue (%) by Region, 2019

Figure 12.19 PRA Health Sciences, Inc.: Revenue ($m), AGR (%), 2015-2019

Figure 12.20 PRA Health Sciences, Inc.: Business Segment Revenue Share (%), 2019

Figure 12.21 PRA Health Sciences, Inc.: Breakdown of Revenue (%) by Region, 2019

Figure 12.22 Charles River Laboratories: Revenue ($m), AGR (%), 2015-2019

Figure 12.23 Charles River Laboratories: Business Segment Revenue Share (%), 2019

Figure 12.24 Charles River Laboratories: Breakdown of Revenue (%) by Region, 2019

Figure 12.25 Charles River Laboratories: Breakdown of Revenue (%) by Region, 2019

Figure 12.26 Boehringer Ingelheim: Revenue ($m), AGR (%), 2014-2018

Figure 12.27 Boehringer Ingelheim: Business Segment Revenue Share (%), 2019

Figure 12.28 Boehringer Ingelheim: Breakdown of Revenue (%) by Region, 2019

Figure 12.29 Meridian Life Science: Revenue ($m), AGR (%), 2015-2019

Figure 12.30 Meridian Life Science: Business Segment Revenue Share (%), 2019

Figure 12.31 Meridian Life Science: Breakdown of Revenue (%) by Region, 2019

Figure 14.1 Vaccine Contact Manufacturing Market: Comparison of Revenue ($m Forecasts for Total Market* and Market for Vaccine Contract Manufacturing Indication, 2018-2030

Figure 14.2 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($m) 2018, 2024, and 2030

Figure 14.3 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2018

Figure 14.4 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2024

Figure 14.5 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2030

Figure 14.6 The Global Vaccine Contract Manufacturing Market Forecast by Region: Revenue (US$m), 2018, 2024, and 2030

List of Tables

Table 2.1 Timeline of Key Events in Vaccine Development, c.1000 AD – Present

Table 3.1 Vaccine Contract Manufacturing Market by Vaccine Type, 2020

Table 3.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 3.3 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 3.4 Global Vaccine Contract Manufacturing Market by Vaccine Type: CAGR (%), 2020-2024, 2024-2030, 2020-2030

Table 3.5 Global Attenuated Vaccine Market: Revenue* ($m), AGR (%) and CAGR (%), 2018-2030

Table 3.6 Global Inactivated Vaccine Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030

Table 3.7 Global Fluoroquinolones Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 3.8 Global Subunit Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 3.9 Global Toxoid Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 3.10 Global Others Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.1 Vaccine Contract Manufacturing Market by Workflow, 2020

Table 4.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.3 Global Vaccine Contract Manufacturing Market by Workflow: CAGR (%), 2020-2024, 2024-2030, 2020-2030

Table 4.4 Global Vaccine Contract Manufacturing (Downstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.5 Global Fill & Finish Operations Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.6 Global Analytical & QC studies Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.7 Global Packaging Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.8 Global Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.9 Global Mammalian Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.10 Global Bacterial Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.11 Global Yeast Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.12 Global Baculovirus/Insect Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 4.13 Global Others Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 5.1 Vaccine Contract Manufacturing Market by Application, 2020

Table 5.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 5.3 Global Vaccine Contract Manufacturing Market by Application: CAGR (%), 2020-2024, 2024-2030, 2020-2030

Table 5.4 Global Paediatric Vaccines Market: Revenue* ($m), AGR (%) and CAGR (%), 2018-2030

Table 5.5 Global Adult Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030

Table 5.6 Global Influenza Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 5.7 Global Therapeutic Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 6.1 Global Vaccine Contract Manufacturing Market by Region: Revenue ($ m), 2018 and 2019

Table 6.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 6.3 Global Vaccine Contract Manufacturing Market by Region: CAGR (%), 2020-2024, 2024-2030, 2020-2030

Table 6.4 Global Vaccine Contract Manufacturing Market by Region: Market Share (%), 2019, 2024, 2030

Table 7.1 North America Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 7.2 North America Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 7.3 North America Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 7.4 North America Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 7.5 North America Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 7.6 North America Vaccine Contract Manufacturing Market Forecast, By Class: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 7.7 U.S. Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 7.8 Canada Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.1 Europe Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2019

Table 8.2 Europe Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.3 Europe Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.4 Europe Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.5 Europe Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.6 Europe Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.7 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.8 Global Vaccine Contract Manufacturing Market by Region: CAGR (%), 2020-2024, 2024-2030, 2020-2030

Table 8.9 Germany Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.10 France Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.11 U.K. Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.12 Italy Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.13 Spain Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 8.14 Rest of Europe Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 9.1 Global Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2019

Table 9.2 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 9.3 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 9.4 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 9.5 Asia Pacific Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 9.6 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 9.7 Asia-Pacific Vaccine Contract Manufacturing Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2018-2030

Table 9.8 Japan Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 9.9 China Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 9.10 India Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 9.11 Rest of Asia Pacific Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 10.1 Latin America Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2019

Table 10.2 Latin America Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 10.3 Latin America Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 10.4 Latin America Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 10.5 Latin America Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 10.6 Latin America Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 10.7 Latin America Vaccine Contract Manufacturing Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2018-2030

Table 10.8 Brazil Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 10.9 Mexico Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 10.10 Rest of Latin America Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 11.1 Middle East & Africa Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2018

Table 11.2 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 11.3 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 11.4 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 11.5 Middle East & Africa Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 11.6 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 11.7 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2018-2030

Table 11.8 Saudi Arabia Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 11.9 South Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 11.10 Rest of Middle East & Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030

Table 12.1. Lonza Group AG: Overview, 2020

Table 12.2 Lonza: Revenue ($m), AGR (%), 2015-2019

Table 12.3 Pfizer, Inc.: Overview, 2020

Table 12.4 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018

Table 12.5 Merck & Co., Inc.: Overview, 2020

Table 12.6 Merck & Co, Inc.: Revenue ($m), AGR (%), 2015-2019

Table 12.7 AbbVie: Overview, 2020

Table 12.8 AbbVie: Revenue ($m), AGR (%), 2015-2019

Table 12.9. Baxter: Overview, 2020

Table 12.10 Baxter: Revenue ($m), AGR (%), 2014-2018

Table 12.11. Catalent, Inc.: Overview, 2020

Table 12.12 Catalent, Inc.: Revenue ($m), AGR (%), 2015-2019

Table 12.13. PRA Health Sciences, Inc.: Overview, 2020

Table 12.14 PRA Health Sciences, Inc.: Revenue ($m), AGR (%), 2015-2019

Table 12.15. KBI Biopharma, Inc.: Overview, 2020

Table 12.16. Charles River Laboratories.: Overview, 2020

Table 12.17 Charles River Laboratories: Revenue ($m), AGR (%), 2015-2019

Table 12.18. Boehringer Ingelheim: Overview, 2020

Table 12.19 Boehringer Ingelheim: Revenue ($m), AGR (%), 2014-2018

Table 12.20. IDT Biologika GmbH: Overview, 2020

Table 12.21. Meridian Life Science: Overview, 2020

Table 12.22 Meridian Life Science: Revenue ($m), AGR (%), 2015-2019

Table 13.1 SWOT Analysis of the Global Vaccine Contract Manufacturing Market, 2020-2030

Figure 13.2 Vaccine Contract Manufacturing Market Drivers & Restraints 2020-2030

Table 14.1 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($m), and CAGR (%), 2018, 2024 and 2030

Table 14.2 Global Vaccine Contract Manufacturing Market by Vaccine Type: CAGR (%), 2018, 2024, 2030

Table 14.3 Global Vaccine Contract Manufacturing Market by Region: CAGR (%), 2018, 2024, 2030

AbbVie

Allevi

AMRI

Anacor

Arabio

AstraZeneca

Avid Bioservices

Baxter BioPharma Solutions

Baxter International Inc.

Beijing Tiantan Biological Products

BioKangtai

BioNTech

Bit Bio

Boehringer Ingelheim Biopharmaceuticals Gmbh

Bristol-Myers Squibb

Catalent, Inc.

Charles River Laboratories

DiNAQOR AG

Frost & Sullivan

Galderma

Gardasil

GE Healthcare

GenePOC Inc.

GlaxoSmithKline

GSAL

HemaCare Corporation

Hospira

IDT Biologika GmbH

Indapta Therapeutics

JSR Life Sciences

KBI Biopharma

LONZA

MaSTherCell

Merck KGaA

Meridian Life Science

Navrogen Inc.

Novartis

Pfizer CentreOne

Pfizer Inc.

PRA Health Sciences

Roche

Sanofi S.A.

Spirig Pharma

ThermoVax

Zumutor Biologics, Inc.

Other Organisations Mentioned in This Report

Biomedical Advanced Research and Development Authority (BARDA)

Center for Disease Control (CDC)

Centers for Disease Control and Prevention

China Food and Drug Administration (CFDA)

Contract Pharma Outsourcing Survey

Defense Advanced Research Projects Agency (DARPA)

Department of Health and Human Services (HHS)

Emory University

European Medical Agency

Food and Drug Administration (FDA)

Global Vaccine Action Plan

Government of Canada

Gulf Cooperation Council Member States

National Institute of Allergy and Infectious Diseases (NIAID)

PATH

U.S. Department of Health and Human Services Office

U.S. Department of Homeland Security

United Nations Children's Fund

World Health Assembly

World Health Organisation (WHO)

Download sample pages

Complete the form below to download your free sample pages for Vaccine Contract Manufacturing Market Forecast 2020-2030

Download sample pages

Complete the form below to download your free sample pages for Vaccine Contract Manufacturing Market Forecast 2020-2030

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033

The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033

31 May 2023

READ

Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033

The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.

26 May 2023

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033

The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033

24 May 2023

READ

Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033

The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033

23 May 2023

READ

Industries > Pharma > Vaccine Contract Manufacturing Market Forecast 2020-2030

Back to Pharma Reports

Vaccine Contract Manufacturing Market Forecast 2020-2030

Prospects for Attenuated Vaccine, Inactivated Vaccine, Fluoroquinolones, Subunit Vaccines, Toxoid Vaccines PLUS analysis in leading companies within Vaccine Contract Manufacturing

Download sample pages

Related reports

Global Clinical Trial Management System Market Forecast 2020-2030

Global Medical Device Contract Manufacturing Market Forecast 2019-2029

Vaccines Sales Market Report 2020-2030

Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

Biologics Market Trends and Forecasts 2019-2029

Clinical Trial Supply and Logistics Market for Pharma 2020-2030

Influenza Vaccines Market Report 2020-2030

Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030

Global Pharma Contract Sales Market Forecast 2020-2030

eClinical Solution Market Report 2019-2029

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033

Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033

Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033

Our Clients